Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

83.3%

-3.3% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (6)
Early P 1 (2)
P 2 (4)
P 3 (2)

Trial Status

Completed10
Enrolling By Invitation3
Recruiting3
Not Yet Recruiting2
Terminated2

Trial Success Rate

83.3%

Benchmark: 86.6%

Based on 10 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07783165Not ApplicableNot Yet RecruitingPrimary

Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Ichthyosis

NCT05295732Phase 3CompletedPrimary

The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis

NCT03417856Enrolling By InvitationPrimary

Defining the Skin and Blood Biomarkers of Ichthyosis

NCT05954416Recruiting

FARD (RaDiCo Cohort) (RaDiCo-FARD)

NCT07050810Early Phase 1Enrolling By Invitation

Thera-Clean® Microbubbles System in Patients With Skin Diseases

NCT03464994Not ApplicableCompletedPrimary

Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)

NCT04697056Phase 2TerminatedPrimary

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis

NCT06136403Phase 2Recruiting

A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

NCT07066150Not ApplicableCompleted

A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement

NCT06330350Recruiting

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

NCT06330324Enrolling By InvitationPrimary

Reproductive Options in Inherited Skin Diseases

NCT04549792Early Phase 1CompletedPrimary

An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

NCT06362447Phase 2Not Yet RecruitingPrimary

Efficacy of Injectable Gentamicin in Hereditary Ichthyosis

NCT03641261Not ApplicableCompletedPrimary

Therapeutic Education Using an Internet Application in Hereditary Ichthyosis

NCT00074685Completed

National Registry for Ichthyosis and Related Disorders

NCT03041038Phase 2CompletedPrimary

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses

NCT03796052Not ApplicableCompletedPrimary

Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients

NCT03051347Not ApplicableCompleted

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

NCT02655861TerminatedPrimary

A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis

NCT00004690Phase 3CompletedPrimary

Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis

Showing all 20 trials

Research Network

Activity Timeline